Related references
Note: Only part of the references are listed.Combined analysis of plasma metabolome and intestinal microbiome sequencing to explore jiashen prescription and its potential role in changing intestine-heart axis and effect on chronic heart failure
Xialian Cui et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)
Effects of Buyang Huanwu Decoction on Intestinal Barrier, Intestinal Flora, and Trimethylamine Oxide in Rats with Heart Failure
Weng Jie-qiong et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2023)
Trimethylamine oxide: a potential target for heart failure therapy
Shichao Lv et al.
HEART (2022)
Sequence meets function-microbiota and cardiovascular disease
Myungsuk Kim et al.
CARDIOVASCULAR RESEARCH (2022)
Advancement of Traditional Chinese Medicine in Regulation of Intestinal Flora: Mechanism-based Role in Disease Management
Zezhen Wu et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2022)
Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms
Patrice D. Cani et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)
Lactobacillus acidophilus and HKL Suspension Alleviates Ulcerative Colitis in Rats by Regulating Gut Microbiota, Suppressing TLR9, and Promoting Metabolism
Kasimujiang Aximujiang et al.
FRONTIERS IN PHARMACOLOGY (2022)
Qige Huxin Formula Attenuates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Protecting Intestinal Integrity
Lipeng Shi et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2022)
TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review
Ye Zixin et al.
FRONTIERS IN PHARMACOLOGY (2022)
Protective Effect of Shengmaiyin in Myocardial Hypertrophy-Induced Rats: A Genomic Analysis by 16S rDNA
Sitong Ming et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2022)
Bacterial diversity in the intestinal mucosa of heart failure rats treated with Sini Decoction
Zhenyu Zhao et al.
BMC COMPLEMENTARY MEDICINE AND THERAPIES (2022)
TMAO: how gut microbiota contributes to heart failure
Yixin Zhang et al.
TRANSLATIONAL RESEARCH (2021)
Gut microbes in cardiovascular diseases and their potential therapeutic applications
Ling Jin et al.
PROTEIN & CELL (2021)
Therapeutic mechanisms of traditional Chinese medicine to improve metabolic diseases via the gut microbiota
Hai-Yu Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
The Gut Microbiome of Heart Failure With Preserved Ejection Fraction
Anna L. Beale et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Chronic opioid use modulates human enteric microbiota and intestinal barrier integrity
Angelica Cruz-Lebron et al.
GUT MICROBES (2021)
Prevention and treatment of chronic heart failure through traditional Chinese medicine: Role of the gut microbiota
Qiujin Jia et al.
PHARMACOLOGICAL RESEARCH (2020)
Low fibre intake is associated with gut microbiota alterations in chronic heart failure
Cristiane C. K. Mayerhofer et al.
ESC HEART FAILURE (2020)
Gut microbiota metabolites as integral mediators in cardiovascular diseases (Review)
Ying Zhu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2020)
Reduction of intestinal trimethylamine by probiotics ameliorated lipid metabolic disorders associated with atherosclerosis
Xi Liang et al.
NUTRITION (2020)
Gut Microbiota in Hypertension and Atherosclerosis: A Review
Barbara J. H. Verhaar et al.
NUTRIENTS (2020)
The cardiac protection of Baoyuan decoction via gut-heart axis metabolic pathway
Zhiyong Du et al.
PHYTOMEDICINE (2020)
The Role of Butyrate in Attenuating Pathobiont-Induced Hyperinflammation
Jiezhong Chen et al.
IMMUNE NETWORK (2020)
Gut microbe-derived metabolite trimethylamine N-oxide induces cardiac hypertrophy and fibrosis
Zehua Li et al.
LABORATORY INVESTIGATION (2019)
Dendrobium huoshanense polysaccharide regionally regulates intestinal mucosal barrier function and intestinal microbiota in mice
Song-Zi Xie et al.
CARBOHYDRATE POLYMERS (2019)
The role of intestinal microbiota in cardiovascular disease
Mengchao Jin et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Heart failure drug treatment
Patrick Rossignol et al.
LANCET (2019)
Adverse Drug Reactions to Guideline-Recommended Heart Failure Drugs in Women A Systematic Review of the Literature
Sophie H. Bots et al.
JACC-HEART FAILURE (2019)
Intestinal Microbiota in Cardiovascular Health and Disease
W. H. Wilson Tang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
The interplay between microbiota-dependent metabolite trimethylamine N-oxide, Transforming growth factor β/SMAD signaling and inflammasome activation in chronic kidney disease patients: A new mechanistic perspective
Omnia Safwat El-Deeb et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Current understanding of gut microbiota alterations and related therapeutic intervention strategies in heart failure
Xi Chen et al.
CHINESE MEDICAL JOURNAL (2019)
Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-κB and notch signalling pathways
Qiuke Hou et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure
Qiujin Jia et al.
CARDIOVASCULAR THERAPEUTICS (2019)
Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012-2015
Guang Hao et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage
Hendrik Bartolomaeus et al.
CIRCULATION (2019)
Loss of Gut Microbiota Alters Immune System Composition and Cripples Postinfarction Cardiac Repair
Tony W. H. Tang et al.
CIRCULATION (2019)
Dietary metabolism, the gut microbiome, and heart failure
W. H. Wilson Tang et al.
NATURE REVIEWS CARDIOLOGY (2019)
Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway
Rajbir Singh et al.
NATURE COMMUNICATIONS (2019)
Urinary Levels of Trimethylamine-N-Oxide and Incident Coronary Heart Disease: A Prospective Investigation Among Urban Chinese Adults
Danxia Yu et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
The role of splanchnic congestion and the intestinal microenvironment in the pathogenesis of advanced heart failure
Vincenzo B. Polsinelli et al.
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE (2019)
Non-Ischemic Heart Failure With Reduced Ejection Fraction Is Associated With Altered Intestinal Microbiota
Themistoklis Katsimichas et al.
CIRCULATION JOURNAL (2018)
Nephrotoxicity and Chinese Herbal Medicine
Bo Yang et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Binding of methimazole and NADP(H) to human FMO3: In vitro and in silico studies
Chongliang Gao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts
Martin Kummen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Intestinal barriers protect against disease
Sandra Citi
SCIENCE (2018)
Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients
Xiao Cui et al.
SCIENTIFIC REPORTS (2018)
TGR5 activation induces cytoprotective changes in the heart and improves myocardial adaptability to physiologic, inotropic, and pressure-induced stress in mice
Zeena Eblimit et al.
CARDIOVASCULAR THERAPEUTICS (2018)
Astragalus membranaceus (Fisch.) Bunge repairs intestinal mucosal injury induced by LPS in mice
Yizhe Cui et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)
High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice
Francine Z. Marques et al.
CIRCULATION (2017)
Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure
Cristiane C. K. Mayerhofer et al.
JOURNAL OF CARDIAC FAILURE (2017)
Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction 5-Year Outcomes
Kevin S. Shah et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Trimethylamine N-oxide impairs pyruvate and fatty acid oxidation in cardiac mitochondria
Marina Makrecka-Kuka et al.
TOXICOLOGY LETTERS (2017)
Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide Contributes to Cardiac Dysfunction in Western Diet-Induced Obese Mice
Kui Chen et al.
FRONTIERS IN PHYSIOLOGY (2017)
Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure
Takehiro Kamo et al.
PLOS ONE (2017)
Heart failure is associated with depletion of core intestinal microbiota
Mark Luedde et al.
ESC HEART FAILURE (2017)
Trimethylamine N-oxide in atherogenesis: impairing endothelial self-repair capacity and enhancing monocyte adhesion
GuoHua Ma et al.
BIOSCIENCE REPORTS (2017)
Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review
Evelien E. S. van Riet et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Trimethylamine N-oxide and prognosis in acute heart failure
Toru Suzuki et al.
HEART (2016)
Hospitalized Patients with Heart Failure and Common Bacterial Infections: A Nationwide Analysis of Concomitant Clostridium Difficile Infection Rates and In-Hospital Mortality
Petra Mamic et al.
JOURNAL OF CARDIAC FAILURE (2016)
Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity
Yuhee Ryu et al.
SCIENTIFIC REPORTS (2016)
Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-κB
Marcus M. Seldin et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Pathogenic Gut Flora in Patients With Chronic Heart Failure
Evasio Pasini et al.
JACC-HEART FAILURE (2016)
The intestinal microbiota and its role in human health and disease
Keiko Kataoka
JOURNAL OF MEDICAL INVESTIGATION (2016)
Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease
Diede Fennema et al.
DRUG METABOLISM AND DISPOSITION (2016)
Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis
Zeneng Wang et al.
CELL (2015)
Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function
Caleb J. Kelly et al.
CELL HOST & MICROBE (2015)
Innate Immunity and the Failing Heart The Cytokine Hypothesis Revisited
Douglas L. Mann
CIRCULATION RESEARCH (2015)
Safety Surveillance of Traditional Chinese Medicine: Current and Future
Shwu-Huey Liu et al.
DRUG SAFETY (2015)
Probiotic therapy with Saccharomyces boulardii for heart failure patients: A randomized, double-blind, placebo-controlled pilot trial
Annelise C. Costanza et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis
Yuji Nagatomo et al.
JOURNAL OF CARDIAC FAILURE (2015)
Traditional Chinese medication for cardiovascular disease (vol 12, pg 115, 2015)
Pan-Pan Hao et al.
NATURE REVIEWS CARDIOLOGY (2015)
Advantages, Disadvantages, and Trend of Integrative Medicine in the Treatment of Heart Failure
PeiYing Zhang
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
Co-Administration of Cholesterol-Lowering Probiotics and Anthraquinone from Cassia obtusifolia L. Ameliorate Non-Alcoholic Fatty Liver
Lu Mei et al.
PLOS ONE (2015)
Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats
Xu Zhang et al.
SCIENTIFIC REPORTS (2015)
Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments
Carson Ka-Lok Lo et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
The heart and the gut
Gerhard Rogler et al.
EUROPEAN HEART JOURNAL (2014)
The Global Health and Economic Burden of Hospitalizations for Heart Failure Lessons Learned From Hospitalized Heart Failure Registries
Andrew P. Ambrosy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine-N-Oxide in Patients With Heart Failure Refining the Gut Hypothesis
W. H. Wilson Tang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Intestinal Blood Flow in Patients With Chronic Heart Failure A Link With Bacterial Growth, Gastrointestinal Symptoms, and Cachexia
Anja Sandek et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition
Pamela V. Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Gut microbiota, the pharmabiotics they produce and host health
Elaine Patterson et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2014)
Gut microbiota and GLP-1
Amandine Everard et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2014)
Heart failure: preventing disease and death worldwide
Piotr Ponikowski et al.
ESC HEART FAILURE (2014)
TNF-α Modulation of Intestinal Epithelial Tight Junction Barrier Is Regulated by ERK1/2 Activation of Elk-1
Rana Al-Sadi et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury
Jun Pu et al.
EUROPEAN HEART JOURNAL (2013)
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Yukihiro Furusawa et al.
NATURE (2013)
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis
Patrick M. Smith et al.
SCIENCE (2013)
PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts
Elaine M. Beller et al.
PLOS MEDICINE (2013)
Bile Acids Regulate Cardiovascular Function
Sandeep Khurana et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2011)
Heart Failure 1 In search of new therapeutic targets and strategies for heart failure: recent advances in basic science
Ajay M. Shah et al.
LANCET (2011)
The Sympathetic Nervous System in Heart Failure Physiology, Pathophysiology, and Clinical Implications
Filippos Triposkiadis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Kendle M. Maslowski et al.
NATURE (2009)
SYSTEMIC INFLAMMATION INCREASES INTESTINAL PERMEABILITY DURING EXPERIMENTAL HUMAN ENDOTOXEMIA
Falco Hietbrink et al.
SHOCK (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Farnesoid X Receptor Antagonizes Nuclear Factor κB in Hepatic Inflammatory Response
Yan-Dong Wang et al.
HEPATOLOGY (2008)
Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model
Francois-Pierre J. Martin et al.
MOLECULAR SYSTEMS BIOLOGY (2008)
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
Harry Sokol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Altered intestinal function in patients with chronic heart failure
Anja Sandek et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Assessing heterogeneity in meta-analysis:: Q statistic or I2 index?
Tania B. Huedo-Medina et al.
PSYCHOLOGICAL METHODS (2006)
Early growth response-1 in cardiovascular pathobiology
LM Khachigian
CIRCULATION RESEARCH (2006)
Inflammatory mediators in chronic heart failure: An overview
SD Anker et al.
HEART (2004)
Selective intestinal decontamination in advanced chronic heart failure: a pilot trial
VM Conraads et al.
EUROPEAN JOURNAL OF HEART FAILURE (2004)
Fatal adverse drug events: the paradox of drug treatment
I Buajordet et al.
JOURNAL OF INTERNAL MEDICINE (2001)
Short-chain fatty acids and human colonic function: Roles of resistant starch and nonstarch polysaccharides
DL Topping et al.
PHYSIOLOGICAL REVIEWS (2001)
Phylogenetic relationships of butyrate-producing bacteria from the human gut
A Barcenilla et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2000)
Share Paper
